The firm primarily focuses on investing in biotechnology startups, with a preference for companies that are 2-3 years old. They typically participate in investment rounds with three other partners, and their notable sponsors include Carebridge Holdings, Apricot Capital, Trustbridge Partners, and GP Healthcare Capital. Despite being based in Switzerland, the majority of their investments are in China. In 2018, they were particularly active, completing multiple deals ranging from $10 to $50 million. One of their successful portfolio companies is GenomiCare Biotechnology.